ImmuPharma PLC (LSE: IMM), specialist drug discovery and development company, this morning told DirectorsTalk that Tim McCarthy, Chairman, will be presenting at an investor evening hosted by Turner Pope Investments (TPI) Ltd. TPI acted as agent in the recent £10 million fundraise by ImmuPharma.
The event will be held on Monday 26th February 2018 in London, EC2 and will commence at 6pm. Further details on the event will be provided upon registration. To Register your interest, please email lisa.baderoon@immupharma.com and info@turnerpope.com or call 0203 621 4120.